Nivelles, Belgium EU, and Little Rock, Arkansas, USA — June 9, 2026 — Quantoom Biosciences, a full-stack RNA manufacturing partner for mRNA- and saRNA-based vaccines and therapeutics, today announced a partnership with Labscoop to expand North American access to Quantoom products. Under the agreement, Labscoop will serve as a sales and business partner for Quantoom’s offerings across the region, connecting life science researchers with Quantoom’s technology and enabling solutions.
Quantoom’s products will soon be available on the Labscoop Marketplace, designed to help life science researchers streamline ordering, save time, and reduce resource burden. In addition, the collaboration will leverage Fulfillment by Labscoop (FBL), enabling Quantoom to reach North American clients with shipping in as little as one business day.
“Quantoom is committed to providing turnkey RNA production solutions to the life-science industry. By partnering with Labscoop, we’re expanding the speed and simplicity with which North American teams can leverage our technology and expand their research to RNA-based treatments —supporting researchers as they move faster from concept to experimentation.”
“We’re excited to add Quantoom Biosciences products to the Labscoop Marketplace and strengthen service for labs across North America,” said Johann Vidanage, VP Sales – North America at Labscoop. “With FBL, labs can benefit from quicker fulfillment while keeping procurement streamlined—helping teams focus on science.”
About Quantoom Biosciences
Quantoom Biosciences is a full-stack RNA partner providing turnkey solutions for mRNA- and saRNA-based vaccines and therapeutics, covering the full workflow from sequence design to RNA production and LNP formulation. Its mission is to provide any player of the life-science / biotech sector with tools to rapidly translate their science into life-changing RNA medicine.
Its N-Force toolbox relies on 3 core elements to turn any antigen into a (sa)mRNA-LNP drug product: Ncode for sequence design and optimization, Ntensify® for RNA production and Ncapsulate® for RNA-LNP formulation. Launched in 2023, the Ntensify solution enables fully integrated, scalable RNA production by combining processes, equipment, reagent mixes, and disposables and has gained global adoption, being recognized for performance and ease-of-use. Beyond technology, Quantoom Biosciences assists its partners by providing extensive enabling solutions, ranging from strategic R&D partnerships to sequence design & optimization. For more information, visit www.quantoom.com.
About Labscoop
Labscoop builds team-centric eCommerce experiences for life science researchers and laboratory organizations, helping them reduce purchasing friction and improve operational efficiency through marketplace access and fulfillment services. For more information, visit www.labscoop.com.
Contacts
Quantoom Biosciences — Thomas GUYON, Product Marketing (t.guyon@quantoom.com)
Labscoop — Johann Vidanage, VP Sales, North America (johann.vidanage@labscoop.com)
